Supplemental Table 3: Mutation frequencies in invasive ovarian cancer cases and controls and risk of ovarian cancer in the NHS, NHSII, and CPSII</p
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Supplemental Table 2: Mutation frequencies in ovarian cancer cases and controls and risk of ovarian ...
Supplemental Table 5: Mutation frequencies in ovarian cancer cases and controls in the NHS, NHSII, a...
Supplemental Table 4: Mutation frequencies in high grade serous, endometroid, or poorly differentiat...
Supplemental Table 6: Total number of mutations across 12 cancer predisposing genes among ovarian ca...
Supplemental Table 1: Characteristics from cohort (2004 NHS; 2007 NHSII, and baseline in CPSII) comp...
Supplemental Figure 1: Kaplan-Meier survival curves for all-cause mortality among cases with Type II...
Supplemental Figure 2: Kaplan-Meier survival curves for ovarian cancer-specific mortality among case...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 are associated with increased ri...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Supplemental Table 2: Mutation frequencies in ovarian cancer cases and controls and risk of ovarian ...
Supplemental Table 5: Mutation frequencies in ovarian cancer cases and controls in the NHS, NHSII, a...
Supplemental Table 4: Mutation frequencies in high grade serous, endometroid, or poorly differentiat...
Supplemental Table 6: Total number of mutations across 12 cancer predisposing genes among ovarian ca...
Supplemental Table 1: Characteristics from cohort (2004 NHS; 2007 NHSII, and baseline in CPSII) comp...
Supplemental Figure 1: Kaplan-Meier survival curves for all-cause mortality among cases with Type II...
Supplemental Figure 2: Kaplan-Meier survival curves for ovarian cancer-specific mortality among case...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 are associated with increased ri...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...